Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Sex differences play roles in how patients respond to brain diseases

Men and women are impacted differently by brain diseases, like Alzheimer's disease and Parkinson's disease. Researchers are urging their colleagues to remember those differences when researching treatments and cures.

16 Mar 2021

Study proves that postural orthostatic tachycardia syndrome may be an autoimmune disorder

The symptoms of postural orthostatic tachycardia syndrome, or POTS, can be as varied as they are confounding. There can be fatigue, pain, bleeding disorders and anxiety. Heart palpitations and lightheadedness are common.

16 Mar 2021

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Brazilian researchers who study a native venomous fish have confirmed a route to drug development for the treatment of chronic inflammatory diseases such as multiple sclerosis and asthma.

10 Mar 2021

Study identifies key gene associated with age-related brain deterioration

A new study led by the University of Portsmouth has identified that one of the major factors of age-related brain deterioration is the loss of a substance called myelin.

10 Mar 2021

Functional connectivity in brain's fatigue network changes in response to cognitive fatigue

Kessler Foundation researchers have demonstrated changes in the functional connectivity within the 'fatigue network' in response to cognitive fatigue.

8 Mar 2021

SARS-CoV-2 proteins are potent suppressors of innate immunity

A new study describes the strong immune-suppressing activity of SARS-CoV-2 genes, among other coronavirus genes.

5 Mar 2021

Evolutionary forces account for gender imbalance in the occurrence of autism, other health conditions

Evolutionary forces drive a glaring gender imbalance in the occurrence of many health conditions, including autism, a team of genetics researchers has concluded.

4 Mar 2021

Study demonstrates long-term neuropsychological consequences following SARS-CoV-2 infection

The study, published in the pre-print server medRxiv, demonstrates the presence of long-lasting neuropsychological sequelae after COVID-19, regardless of the respiratory disease's severity.

2 Mar 2021

Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

In a study published online February 25, 2021 in The New England Journal of Medicine, a repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia.

1 Mar 2021

Experts highlight need to support people with disabilities in post-pandemic workplace

COVID-19 has wrought havoc on the global economy and the world's public health systems. People with disabilities are more likely to suffer severe cases of the disease.

26 Feb 2021

New approach harnesses disease-causing proteins to combat cancer

Over many decades now, traditional drug discovery methods have steadily improved at keeping diseases at bay and cancer in remission. And for the most part, it's worked well.

26 Feb 2021

Some nutritional supplements may help prevent or mitigate COVID-19 severity

A new study in the Journal of dietary supplements shows that nutritional supplements, including several vitamins and the mineral zinc, may be useful in preventing the infection or reducing its severity if caught.

22 Feb 2021

Companies pan for marketing gold in vaccines

For a decade, Jennifer Crow has taken care of her elderly parents, who have multiple sclerosis. After her father had a stroke in December, the family got serious in its conversations with a retirement community — and learned that one service it offered was covid-19 vaccination.

19 Feb 2021

Blood-clotting protein linked with tumor pathogenesis of CNS B-cell lymphoma

In people with central nervous system (CNS) lymphoma, cancerous B cells--a type of white blood cell--accumulate to form tumors in the brain or spinal cord, often in close proximity to blood vessels.

17 Feb 2021

Simulating an overactive autoimmune response leads to changes in the brain region

Researchers at the University of Tsukuba in Japan show that simulating an overactive autoimmune response in mice leads to changes in the hippocampal region of the brain.

17 Feb 2021

Research shows how chemicals in the tumor microenvironment enable cancer to evade attack

A paper published today in Nature shows how chemicals in the areas surrounding tumors--known as the tumor microenvironment--subvert the immune system and enable cancer to evade attack. These findings suggest that an existing drug could boost cancer immunotherapy.

15 Feb 2021

Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis

A new study examines the associations between immunosuppressive disease-modifying therapies (DMTs) used in MS with adverse outcomes in an international cohort of patients with MS COVID-19.

15 Feb 2021

New technology can help develop diagnostic tests for multiple sclerosis

Multiple sclerosis (MS) is the most common neurological disease in young adults, affecting more than 2 million individuals worldwide, with about 1500 cases in Estonia. About 20% of MS patients experience optic neuritis (ON) as the presenting symptom, but not all ON patients develop MS.

12 Feb 2021

Study could help develop drugs for pregnancy maintenance, treat autoimmune diseases

A team of scientists from Immanuel Kant Baltic Federal University with their colleagues from the Institute of Ecology and Genetics of Microorganisms of the Ural Branch of the Russian Academy of Sciences (Perm) studied the effect of trophoblastic β1-glycoprotein in the blood of pregnant women on pro-inflammatory immune cells.

10 Feb 2021

New study to examine the effects of MS disease-modifying therapy on cognitive fatigue

Kessler Foundation researchers have received support from Genentech, a member of the Roche Group, to conduct an investigator-initiated study on the effects of ocrelizumab (Ocrevus) on cognitive fatigue in individuals with relapsing-remitting multiple sclerosis (MS).

8 Feb 2021

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Sex differences play roles in how patients respond to brain diseases

Study proves that postural orthostatic tachycardia syndrome may be an autoimmune disorder

Researchers confirm new drug development route for treating multiple sclerosis, asthma

Study identifies key gene associated with age-related brain deterioration

Functional connectivity in brain's fatigue network changes in response to cognitive fatigue

SARS-CoV-2 proteins are potent suppressors of innate immunity

Evolutionary forces account for gender imbalance in the occurrence of autism, other health conditions

Study demonstrates long-term neuropsychological consequences following SARS-CoV-2 infection

Study: Repurposed arthritis drug did not improve outcomes of patients with severe COVID-19 pneumonia

Experts highlight need to support people with disabilities in post-pandemic workplace

New approach harnesses disease-causing proteins to combat cancer

Some nutritional supplements may help prevent or mitigate COVID-19 severity

Companies pan for marketing gold in vaccines

Blood-clotting protein linked with tumor pathogenesis of CNS B-cell lymphoma

Simulating an overactive autoimmune response leads to changes in the brain region

Research shows how chemicals in the tumor microenvironment enable cancer to evade attack

Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis

New technology can help develop diagnostic tests for multiple sclerosis

Study could help develop drugs for pregnancy maintenance, treat autoimmune diseases

New study to examine the effects of MS disease-modifying therapy on cognitive fatigue

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in